BioCentury
ARTICLE | Company News

Oxford Pharmascience Group, University College London deal

September 17, 2012 7:00 AM UTC

Oxford Pharmascience exercised its option under a deal to license rights from the university to develop and commercialize compounds using Safestat drug delivery technology. Safestat reformulates marke...